Savant Capital LLC Grows Stock Holdings in Teleflex Incorporated $TFX

Savant Capital LLC lifted its position in Teleflex Incorporated (NYSE:TFX) by 81.0% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 18,248 shares of the medical technology company’s stock after buying an additional 8,166 shares during the period. Savant Capital LLC’s holdings in Teleflex were worth $2,233,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. MassMutual Private Wealth & Trust FSB grew its holdings in Teleflex by 57.9% in the third quarter. MassMutual Private Wealth & Trust FSB now owns 210 shares of the medical technology company’s stock worth $26,000 after purchasing an additional 77 shares during the last quarter. Hantz Financial Services Inc. grew its stake in Teleflex by 248.8% during the 3rd quarter. Hantz Financial Services Inc. now owns 279 shares of the medical technology company’s stock worth $34,000 after buying an additional 199 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. acquired a new position in Teleflex during the 3rd quarter valued at about $35,000. True Wealth Design LLC raised its stake in Teleflex by 10,333.3% in the second quarter. True Wealth Design LLC now owns 313 shares of the medical technology company’s stock valued at $37,000 after buying an additional 310 shares during the last quarter. Finally, Quent Capital LLC acquired a new stake in Teleflex in the third quarter worth about $38,000. Institutional investors own 95.62% of the company’s stock.

Teleflex Trading Up 2.5%

Shares of Teleflex stock opened at $108.52 on Monday. The stock has a market cap of $4.80 billion, a PE ratio of -14.76, a price-to-earnings-growth ratio of 1.41 and a beta of 0.92. The firm has a fifty day moving average price of $115.18 and a 200 day moving average price of $119.35. Teleflex Incorporated has a 1 year low of $100.18 and a 1 year high of $180.58. The company has a debt-to-equity ratio of 0.67, a current ratio of 2.57 and a quick ratio of 1.53.

Teleflex (NYSE:TFX) last announced its quarterly earnings results on Thursday, November 6th. The medical technology company reported $3.67 earnings per share for the quarter, topping the consensus estimate of $3.38 by $0.29. The company had revenue of $892.90 million for the quarter, compared to the consensus estimate of $892.79 million. Teleflex had a positive return on equity of 15.64% and a negative net margin of 10.28%.The firm’s revenue for the quarter was up 19.4% compared to the same quarter last year. During the same period last year, the firm earned $3.49 EPS. Equities research analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Analyst Ratings Changes

Several research firms have recently issued reports on TFX. Wall Street Zen downgraded shares of Teleflex from a “buy” rating to a “hold” rating in a report on Saturday, November 15th. Royal Bank Of Canada restated a “sector perform” rating and set a $135.00 price target on shares of Teleflex in a research note on Wednesday, December 17th. Needham & Company LLC raised shares of Teleflex from a “hold” rating to a “buy” rating and set a $138.00 price target for the company in a report on Tuesday, January 27th. Weiss Ratings reissued a “sell (d)” rating on shares of Teleflex in a report on Monday, December 29th. Finally, Truist Financial upped their target price on Teleflex from $120.00 to $135.00 and gave the company a “hold” rating in a research report on Thursday, December 18th. Two research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $139.00.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.